Compare ASTRAZENECA PHARMA with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs TTK HEALTHCARE - Comparison Results

ASTRAZENECA PHARMA     Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA TTK HEALTHCARE ASTRAZENECA PHARMA/
TTK HEALTHCARE
 
P/E (TTM) x 127.0 12.4 1,027.3% View Chart
P/BV x 38.9 1.8 2,165.7% View Chart
Dividend Yield % 0.0 0.9 -  

Financials

 ASTRAZENECA PHARMA   TTK HEALTHCARE
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-18
TTK HEALTHCARE
Mar-19
ASTRAZENECA PHARMA/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,2781,215 105.2%   
Low Rs883610 144.7%   
Sales per share (Unadj.) Rs228.4444.4 51.4%  
Earnings per share (Unadj.) Rs10.417.2 60.1%  
Cash flow per share (Unadj.) Rs16.327.6 58.9%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Dividend yield (eoy) %00.5 0.0%  
Book value per share (Unadj.) Rs98.8177.9 55.5%  
Shares outstanding (eoy) m25.0014.13 176.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x4.72.1 230.3%   
Avg P/E ratio x104.252.9 197.0%  
P/CF ratio (eoy) x66.433.0 201.2%  
Price / Book Value ratio x10.95.1 213.3%  
Dividend payout %029.0 0.0%   
Avg Mkt Cap Rs m27,00812,894 209.5%   
No. of employees `0001.42.3 58.7%   
Total wages/salary Rs m1,5351,307 117.5%   
Avg. sales/employee Rs Th4,210.92,715.7 155.1%   
Avg. wages/employee Rs Th1,132.2565.3 200.3%   
Avg. net profit/employee Rs Th191.1105.4 181.3%   
INCOME DATA
Net Sales Rs m5,7106,279 90.9%  
Other income Rs m12378 158.1%   
Total revenues Rs m5,8336,356 91.8%   
Gross profit Rs m463496 93.4%  
Depreciation Rs m147147 100.5%   
Interest Rs m034 0.0%   
Profit before tax Rs m438393 111.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m179149 120.1%   
Profit after tax Rs m259244 106.3%  
Gross profit margin %8.17.9 102.7%  
Effective tax rate %40.837.9 107.7%   
Net profit margin %4.53.9 116.9%  
BALANCE SHEET DATA
Current assets Rs m3,2092,717 118.1%   
Current liabilities Rs m2,0701,571 131.7%   
Net working cap to sales %20.018.3 109.3%  
Current ratio x1.61.7 89.6%  
Inventory Days Days7232 225.0%  
Debtors Days Days3547 74.9%  
Net fixed assets Rs m790991 79.7%   
Share capital Rs m50141 35.4%   
"Free" reserves Rs m2,4192,373 102.0%   
Net worth Rs m2,4692,514 98.2%   
Long term debt Rs m03 0.0%   
Total assets Rs m4,6054,158 110.8%  
Interest coverage xNM12.6-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.21.5 82.1%   
Return on assets %5.66.7 84.3%  
Return on equity %10.59.7 108.3%  
Return on capital %17.716.9 104.7%  
Exports to sales %03.6 0.0%   
Imports to sales %00.5 0.0%   
Exports (fob) Rs mNA225 0.0%   
Imports (cif) Rs mNA31 0.0%   
Fx inflow Rs m300225 133.0%   
Fx outflow Rs m2,01571 2,833.5%   
Net fx Rs m-1,715154 -1,113.2%   
CASH FLOW
From Operations Rs m88173 50.8%  
From Investments Rs m-9497 -97.0%  
From Financial Activity Rs mNA-307 0.0%  
Net Cashflow Rs m-6-38 15.1%  

Share Holding

Indian Promoters % 0.0 65.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 0.3 3.7 8.1%  
FIIs % 15.7 5.2 301.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 9.1 25.8 35.3%  
Shareholders   12,856 12,723 101.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   PANACEA BIOTECH  AJANTA PHARMA  SUVEN LIFE SCIENCES  ALEMBIC PHARMA  CADILA HEALTHCARE  

Compare ASTRAZENECA PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty End Flat; Asian Paints, UPL & ITC Among Top Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

ASTRAZENECA PHARMA Announces Quarterly Results (3QFY21); Net Profit Down 21.2% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 211 m (down 21.2% YoY). Sales on the other hand came in at Rs 2 bn (down 10.5% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 71.7% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, TTK HEALTHCARE has posted a net profit of Rs 77 m (up 71.7% YoY). Sales on the other hand came in at Rs 2 bn (up 8.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 13.4% (Quarterly Result Update)

Sep 22, 2020 | Updated on Sep 22, 2020

For the quarter ended June 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 186 m (down 13.4% YoY). Sales on the other hand came in at Rs 2 bn (down 5.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 2.5% (Quarterly Result Update)

May 20, 2020 | Updated on May 20, 2020

For the quarter ended March 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 96 m (down 2.5% YoY). Sales on the other hand came in at Rs 2 bn (up 2.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

Is Intraday Trading For You?(Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution(Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ASTRAZENECA PHARMA SHARE PRICE


May 14, 2021 (Close)

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA 8-QTR ANALYSIS

COMPARE ASTRAZENECA PHARMA WITH

MARKET STATS